HB 1206 - DIGEST

     Provides that, in an effort to reduce the harmful effects of drug-affected infants a woman's primary health care provider shall:

     (1) Screen pregnant and lactating women for nonprescription use of controlled substances while pregnant.  Screening criteria may include, but is not limited to, the criteria developed by the department of health pursuant to chapter 70.83E RCW;

     (2) Convey to the infant's primary health care provider screening findings that would suggest the need for testing of the infant, or conduct the testing; and

     (3) Inform each woman identified by screening for testing of her infant that if her infant is born drug-affected she can have a tubal ligation at no cost to her within six months following the birth if she is eligible for support under RCW 74.09.310, and how to access appropriate chemical dependency treatment.

     Repeals RCW 18.57.930, 18.71.960, 18.79.904, 70.96A.330, and 70.96A.340.